BU-NOT-SET

CONTACT US
Recipharm’s global teams support and engage with their local communities in the fight against COVID-19
  • Corporate
Eyes
Insight
Recipharm launches new virtual inspection and audit tool for customers, in light of COVID-19 outbreak
  • Manufacturing
Eyes
Insight
Recipharm 25 years
  • Corporate
24 years
Brochure
API product list
  • Drug substance
white pills
Fact sheet
Inhibition of 19S proteasome deubiquitinating activity in Schistosoma mansoni affects viability, oviposition, and structural changes
  • Drug substance
Eyes
Insight
The demand for antibiotics and its impact on the pharmaceutical industry since the outbreak of COVID-19
  • Industry trends
Eyes
Insight
Women in leadership
  • Corporate
Eyes
Insight
The state of the oral solid dose development and manufacturing market
  • Drug product
Eyes
Insight
Characterising APIs is Essential for Combo Drug Formulations
  • Drug substance
Eyes
Insight
Insight
  • Drug product
Solving the challenges during oral solid dosage development
Insight
  • Drug product
mRNA vaccine manufacturing: how to unlock success
Insight
  • Manufacturing
Pharma packaging trends under the spotlight
Insight
  • Drug product
Modified release formulation and manufacture
Webinar
  • Drug product
Aseptic manufacturing – design of lines for filling and lyophilisation
Case study
  • Drug product
Avoiding pitfalls in sterile manufacturing
Webinar
  • Drug substance
How to develop a cannabinoid into a drug
eBook
  • Drug product
Golden rules for drug development
Fact sheet
  • Drug product
  • Manufacturing
Packaging services